BioSpace News Archive

Owens & Minor, Inc. (NYSE: OMI) is pleased to announce the hiring of David Myers as SVP & Chief Procurement Officer.

Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced the termination, for material breach, of the agreement with Circassia Pharmaceuticals,

A group of more than 650 nephrologists have joined with Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, to raise $20 million in initial funding and announce the formation of InterWell Health, a population health management company focused on supporting the renal patient population across the full continuum of care.

Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids

EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, announced that it is the winner in this year’s Drug Delivery Technology category given by Fierce Innovation Awards - LifeSciences Edition

Varian (NYSE: VAR) today announced its first quarter fiscal year 2020 earnings release date.

Metablok is the Company’s lead drug candidate for treating organ damage caused by inflammation

BioMed Tech Developer Included in “Electro-Charged Therapeutics” Category Recognizing Companies Creating a Drug-Free Future

Western Governors University and Cayuga Medical Center—a member of Cayuga Health System—have announced a partnership designed to give employees of the comprehensive medical center increased access and flexibility to earn affordable bachelor’s and master’s degrees.

Cycle for Survival, the movement to beat rare cancers, is aiming to raise $2.5 million during their December Challenge campaign.